Group 1 - The FX Super One Middle East launch event took place at the Armani Hotel in Burj Khalifa, Dubai, marking a significant milestone for the company [1] - Distinguished guests included representatives from the Qatari Government, Ajman Royal Family, and various investment groups, indicating strong regional interest and support [1] - Key executives from FF, including Global co-CEO Matthias Aydt and FX brand CEO Max Ma, were present, highlighting the leadership's commitment to the Middle East market [2] Group 2 - The event featured a forward-looking statement, suggesting that the company is focused on transparency regarding factors that may impact business and financial results [3]

Core Points - Visionary Holdings Inc. received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to a delay in filing its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 [1] - The notification does not have an immediate effect on the listing or trading of the Company's shares, and the Company has 60 days to submit a compliance plan [2] - Visionary is actively working with its independent auditor to complete the audit process and file the Form 20-F as soon as possible [3] Company Overview - Visionary Holdings Inc. is a private education service provider based in Markham, Ontario, Canada, operating in both private and public education sectors [4]

Core Viewpoint - Visionary Holdings Inc. has signed a strategic cooperation agreement with Jiangsu Yike Regenerative Medical Technology Co., Ltd. to establish a joint venture, Visionary Yike Stemcell Technologies Inc., aimed at advancing stem cell research and commercialization globally [1][5]. Group 1: Joint Venture Details - The joint venture will focus on stem cell therapy, immune cell engineering, and AI-supported anti-aging diagnostics, leveraging Yike's proprietary platform and GV's global market infrastructure [3]. - GV will hold an 85% equity stake in the joint venture, while Yike will hold 15% [3]. - The joint venture aims to create a vertically integrated regenerative medicine enterprise encompassing R&D, trials, manufacturing, and global sales [3]. Group 2: Location and Infrastructure - The headquarters for the joint venture is proposed to be located at GV's property in Toronto, which spans over 40,000 square meters [2]. - The parties are evaluating the feasibility of developing cleanrooms, low-temperature biostorage, and related infrastructures to support future operations [2]. Group 3: Strategic Importance - The establishment of the joint venture is seen as a transformative milestone for GV's global health strategy, with potential for long-term value creation [4]. - This collaboration is expected to enhance GV's positioning in the North American stem cell sector and reflects a commitment to global innovation and shareholder value [5]. Group 4: Company Background - Visionary Holdings Inc. is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions, operating across North America and Asia [6]. - Jiangsu Yike Regenerative Medicine specializes in regenerative medicine and precision anti-aging technologies, holding numerous international patents and certifications [7].

Core Viewpoint - Visionary Copper and Gold Mines Inc. is initiating a non-brokered private placement to raise up to $3.0 million to fund a drilling campaign at its 100% owned Pt. Leamington Project in Newfoundland [1] Offering Details - The Offering will consist of three components: 1. Up to 1,560,000 hard dollar units (HD Units) priced at C$0.75 each, aiming for gross proceeds of up to C$1,170,000 [2] 2. Up to 1,333,333 flow-through units (FT Units) priced at C$1.11 each, targeting gross proceeds of up to $1,480,000 [2] 3. Up to 267,175 Manitoba flow-through units (MB FT Units) priced at C$1.31 each, with gross proceeds of up to $350,000 [2] Unit Composition - Each HD Unit will consist of one common share and one-half of one transferable common share purchase warrant [3] - Each FT Unit and MB FT Unit will consist of one flow-through common share and one-half of one transferable Warrant [3] Use of Proceeds - Gross proceeds from the sale of FT Units will be allocated to eligible "Canadian exploration expenses" related to the Pt. Leamington Project, with all qualifying expenditures renounced in favor of the subscribers effective December 31, 2025 [4] - Net proceeds from the sale of HD Units will be utilized for working capital and general corporate purposes [4] Company Overview - Visionary Copper and Gold Mines Inc. is focused on advancing its portfolio of base and precious metals deposits in established Canadian mining jurisdictions, particularly the Pt. Leamington Deposit in Newfoundland [7] - The company has reported an indicated mineral resource of 5.0 million tonnes grading 2.5 g/t AuEq, equating to 402,000 ounces of AuEq [7] - The company is also permitting the Rainbow deposit at its Pine Bay Project, with significant mineral resources reported [7]

Core Insights - Visionary Holdings Inc. has completed an equity adjustment to acquire a 51% stake in Sikang (Guangzhou) Health Industry Investment Co., Ltd., marking a significant step in its strategy for global high-quality industry investment [1][3] Group 1: Strategic Synergy and Business Model - The joint venture with Guangzhou Sikang aims to leverage capital and industrial resources to enhance standardized services and global expansion in the Traditional Chinese Medicine (TCM) health preservation sector [1][3] - Guangzhou Sikang has established an industrial ecosystem focused on professional talent education, brand chain expansion, and intelligent resource trading, creating a mature operational model for TCM health services [2][3] Group 2: Business Development and Market Expansion - Prior to the equity adjustment, Guangzhou Sikang made progress in both domestic operations and international exploration, including an initial expansion into the Southeast Asian market with TCM products and services [4] - The company held a TCM Health Preservation Ecosystem Cooperation Conference, gathering over 200 partners to enhance domestic channel cooperation and service standardization [4] Group 3: Long-term Value and Shareholder Returns - Visionary's management emphasizes the long-term growth potential of TCM health preservation, aligning with its strategy to create sustainable shareholder value [5][6] - The company plans to empower the joint venture by providing compliant capital support, connecting global industrial channels, and integrating technologies to promote service standardization [6]

Core Viewpoint - Visionary Holdings Inc. has entered into a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd. to utilize Yike's stem cell technology for diabetes treatment and other regenerative medicine innovations [1][4]. Group 1: Agreement Details - The agreement allows Visionary Holdings to use Yike's proprietary regenerative medicine technology platform and focus on commercialization and clinical applications in areas such as stem cell therapy and cellular rejuvenation [2]. - Revenue-sharing will be based on actual product sales and technology commercialization, with Yike generating revenue from technology licensing and clinical R&D, while Visionary Holdings will benefit from market sales and global business development [3]. Group 2: Market Potential - Diabetes affects over 540 million adults globally, with the treatment market projected to exceed USD 150 billion in 2024, indicating significant growth potential [4]. - Existing diabetes therapies primarily manage symptoms rather than providing a cure, highlighting the importance of Yike's stem cell therapy, which has shown potential for long-term remission and complete cure [4]. Group 3: Future Plans - Visionary Holdings and Yike plan to deepen cooperation in product R&D, clinical validation, and international market expansion, while exploring global certification standards for regenerative medical products [5]. - The collaboration aims to deliver transformative medical solutions and significantly contribute to Visionary Holdings' revenue growth in the upcoming fiscal years [5]. Group 4: Company Overview - Visionary Holdings Inc. is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions, headquartered in Toronto, Canada [6].

Core Insights - Visionary Holdings (Asia) Limited has signed a strategic cooperation agreement with Qianxin Bocheng to establish a long-term partnership aimed at fostering innovation in the aesthetic treatment industry [1][2][4]. Group 1: Strategic Partnership Details - The agreement will enable Qianxin Bocheng to provide policy support, funding, and industrial park facilities, while Visionary Holdings (Asia) will leverage its capital resources and international experience to attract high-quality enterprises [2][6]. - A joint working group will be formed to ensure effective implementation, with regular high-level meetings to review progress and adjust strategies as necessary [3][4]. Group 2: Areas of Cooperation - The cooperation framework includes four core areas: 1. Industrial Park Cooperation, where Qianxin Bocheng will provide facilities and support services, and Visionary Holdings (Asia) will bring in enterprises [6]. 2. Project Incubation, focusing on leveraging industrial investment funds to accelerate the growth of startups in the aesthetic treatment sector [6]. 3. Enterprise Cultivation and M&A Channel, where both parties will identify companies with strong industrial value, with Visionary Holdings (Asia) having priority for acquisitions [6]. 4. Brand and Promotional Activities, including organizing industry summits and forums to enhance influence [6]. Group 3: Strategic Importance - The CEO of Visionary Holdings Inc. emphasized that this cooperation is a significant step in strengthening the company's presence in the aesthetic treatment industry and aims to create long-term value for stakeholders [4].

Core Points - Visionary Metals Corp. has successfully closed a private placement of $1.22 million to advance nickel exploration in Wyoming [1][2] - Teck Resources Limited subscribed for 17,392,193 common shares at $0.07 per share, resulting in gross proceeds of $1,217,454, which represents 9.9% of Visionary's issued and outstanding shares on a non-diluted basis [2] - The funds will be allocated for initial exploration activities on Visionary's 40 square kilometer land package in the Granite Mountains of Central Wyoming [1][2] Company Overview - Visionary Metals Corp. is a Canadian mineral exploration company listed on the TSX Venture Exchange, focusing on new base metals discoveries in Central Wyoming [3] - The company's mission emphasizes responsible exploration and resource development that benefits all stakeholders [3]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - 89bio, Inc. (ETNB) increased by 83% to $14.84 [3] - Aptevo Therapeutics Inc. (APVO) rose by 75% to $2.47 [3] - Psyence Biomedical Ltd. (PBM) saw a 29% increase to $4.82 [3] - Beam Global (BEEM) gained 27% reaching $3.23 [3] - MicroAlgo Inc. (MLGO) was up 14% at $13.06 [3] - Akero Therapeutics, Inc. (AKRO) increased by 12% to $47.50 [3] - Hyperion DeFi, Inc. (HYPD) rose by 11% to $13.69 [3] - Sonnet BioTherapeutics Holdings, Inc. (SONN) increased by 11% to $7.85 [3] - FuelCell Energy, Inc. (FCEL) was up 9% at $8.34 [3] - Robo.ai Inc. (AIIO) gained 6% to $2.05 [3] Premarket Losers - Presidio Property Trust, Inc. (SQFT) decreased by 14% to $7.58 [4] - Aeluma, Inc. (ALMU) fell by 10% to $15.18 [4] - FGI Industries Ltd. (FGI) dropped 10% to $7.65 [4] - Lazydays Holdings, Inc. (GORV) was down 9% at $2.26 [4] - StableX Technologies, Inc. (SBLX) decreased by 8% to $5.40 [4] - Artelo Biosciences, Inc. (ARTL) fell by 8% to $4.48 [4] - SciSparc Ltd. (SPRC) decreased by 8% to $4.10 [4] - Cracker Barrel Old Country Store, Inc. (CBRL) was down 7% at $45.75 [4] - Columbus Circle Capital Corp I (BRR) fell by 7% to $9.42 [4] - Visionary Holdings Inc. (GV) decreased by 7% to $2.58 [4]

Group 1 - Visionary Holdings Inc. has announced a strategic partnership with Jiangsu Yike Regenerative Medicine, a leading regenerative medical research institute in China [1] - This partnership aims to leverage technology-driven solutions in the field of regenerative medicine [1] - The collaboration is expected to enhance research capabilities and expand market reach for both companies [1] Group 2 - The partnership signifies a growing trend in the biotechnology sector, focusing on innovative medical solutions [1] - Visionary Holdings Inc. is positioned to benefit from advancements in regenerative medicine through this alliance [1] - The collaboration may lead to new investment opportunities in the healthcare and biotechnology industries [1]